PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.64%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-22.15%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-41.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-43.79%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-45.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-48.24%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-48.22%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.47%
Share reduction while CX is at 6.09%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.26%
Reduced diluted shares while CX is at 6.09%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.05%
Dividend growth under 50% of CX's 445.42%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
79.61%
OCF growth under 50% of CX's 235.44%. Michael Burry might suspect questionable revenue recognition or rising costs.
82.16%
FCF growth under 50% of CX's 923.79%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-8.62%
Negative 10Y revenue/share CAGR while CX stands at 22.15%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-22.98%
Negative 5Y CAGR while CX stands at 23.60%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
113.92%
10Y OCF/share CAGR under 50% of CX's 437.14%. Michael Burry would worry about a persistent underperformance in cash creation.
2.59%
Below 50% of CX's 38.36%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
18.08%
3Y OCF/share CAGR under 50% of CX's 278.68%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
48.90%
Below 50% of CX's 128.81%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-9.58%
Negative 5Y net income/share CAGR while CX is 119.34%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-51.67%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
131.60%
10Y equity/share CAGR above 1.5x CX's 15.23%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
50.72%
5Y equity/share CAGR above 1.5x CX's 24.80%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.17%
3Y equity/share CAGR 1.25-1.5x CX's 15.31%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
140.45%
Dividend/share CAGR of 140.45% while CX is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
81.94%
5Y dividend/share CAGR at 50-75% of CX's 119.78%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
53.18%
Below 50% of CX's 570.81%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-24.95%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.39%
We show growth while CX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.90%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.28%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.49%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.